GEP20022813B - (54) Vaccine and Immunogenic Complex and/or Mixture Composed of Heat Stress Proteins (HSPs) Derived From Fresh Herbaceous Plant Cells and Method For Their Production - Google Patents
(54) Vaccine and Immunogenic Complex and/or Mixture Composed of Heat Stress Proteins (HSPs) Derived From Fresh Herbaceous Plant Cells and Method For Their ProductionInfo
- Publication number
- GEP20022813B GEP20022813B GEAP20005599A GEAP2000005599A GEP20022813B GE P20022813 B GEP20022813 B GE P20022813B GE AP20005599 A GEAP20005599 A GE AP20005599A GE AP2000005599 A GEAP2000005599 A GE AP2000005599A GE P20022813 B GEP20022813 B GE P20022813B
- Authority
- GE
- Georgia
- Prior art keywords
- derived
- heat stress
- hsps
- stress proteins
- plant cells
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
1. Technical Result Widening of assortment of medicinal preparations for strengthening immune resistance of mammalians. 2. Essence A vaccine comprises immunogenic stress protein-peptide complex and/or mixture consisting of peptides and Heat Stress Proteins (HSPs) of plant origin or from peptides derived in vitro from human or animal urine and Heat Stress Proteins derived from fresh herbaceous plant cells and pharmaceutically acceptable carrier. 3. Field of Application Biochemistry and biotechnology.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GEAP20005599A GEP20022813B (en) | 2000-10-18 | 2000-10-18 | (54) Vaccine and Immunogenic Complex and/or Mixture Composed of Heat Stress Proteins (HSPs) Derived From Fresh Herbaceous Plant Cells and Method For Their Production |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GEAP20005599A GEP20022813B (en) | 2000-10-18 | 2000-10-18 | (54) Vaccine and Immunogenic Complex and/or Mixture Composed of Heat Stress Proteins (HSPs) Derived From Fresh Herbaceous Plant Cells and Method For Their Production |
Publications (1)
Publication Number | Publication Date |
---|---|
GEP20022813B true GEP20022813B (en) | 2002-10-25 |
Family
ID=82309457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GEAP20005599A GEP20022813B (en) | 2000-10-18 | 2000-10-18 | (54) Vaccine and Immunogenic Complex and/or Mixture Composed of Heat Stress Proteins (HSPs) Derived From Fresh Herbaceous Plant Cells and Method For Their Production |
Country Status (1)
Country | Link |
---|---|
GE (1) | GEP20022813B (en) |
-
2000
- 2000-10-18 GE GEAP20005599A patent/GEP20022813B/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU657487B2 (en) | Nucleotide sequence coding for an outer membrane protein from neisseria meningitidis and use of said protein in vaccine preparations | |
NZ326092A (en) | Immunostimulatory composition and method | |
DE69531332D1 (en) | Cloning and expression of a gene encoding Bryodin 1 from Bryonia dioica | |
GR3035050T3 (en) | Method of preparing a viral vector by homologous intermolecular recombination | |
PT1221968E (en) | Method of obtaining cellular immune responses from proteins | |
NO913518L (en) | VACCINES FOR NON-TYPE-TESTABLE HAEMOPHILUS INFLUENZAE. | |
CA2215203A1 (en) | Vaccines for plague | |
AU4545799A (en) | Beta2 microglobulin fusion proteins and high affinity variants | |
EP0672754A4 (en) | Plant virus vector, plasmid, method of expressing foreign gene, and method of acquiring foreign gene product. | |
ATE268384T1 (en) | ANALOGUE OF HAEMOPHILUS HIN47 WITH REDUCED PROTEASE ACTIVITY | |
Vane et al. | Genetic engineering and pharmaceuticals | |
GEP20022813B (en) | (54) Vaccine and Immunogenic Complex and/or Mixture Composed of Heat Stress Proteins (HSPs) Derived From Fresh Herbaceous Plant Cells and Method For Their Production | |
GB9914480D0 (en) | Use of peptides | |
EP1801216A3 (en) | Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation | |
GEP20012489B (en) | Use of Natural Human α-Interferon | |
GR3035006T3 (en) | New conjugates, consisting of a glycoprotein and a nucleic acid-binding substance. | |
WO2002045743A3 (en) | Hcv vaccines | |
WO2003072750A3 (en) | Expression of hiv-related proteins in plants | |
JPH01287097A (en) | Antitumor protein | |
AU2002223860A1 (en) | Nucleic acid vaccine comprising a fusion protein including an adjuvant sequence from a plant viral coat protein | |
Ristau et al. | Bovine leucosis virus challenge infection of calves following application of BL-3 cells | |
UA5743C2 (en) | Preparation of biologically active tissue substances possessing regenerative activity and method for its production | |
Hanagarth et al. | The cell-binding carboxyterminal undecapeptide of SV40 tumour antigen provides protective cell-dependent immunity | |
ATE317905T1 (en) | MEDICINAL PRODUCTS CONTAINING AT LEAST A PART OF THE UL84 PROTEIN OF THE CYTOMEGALOVIRUS, USE OF POLYPEPTIDES ACCORDING TO THE AMINO ACID SEQUENCE OF THE UL84 PROTEIN AND METHOD FOR INTRODUCING UL84 INTO TARGET CELLS | |
Favrot et al. | Correspondence re: John R. Yanelli et al., Enhancement of Human Lymphokine-activated Killer Cell Cytolysis and a Method for Increasing Lymphokine-activated Killer Cell Yields to Cancer Patients. Cancer Res., 48: 5696-5700, 1988 |